MedTrace Logo

Analysis of the Arterial Pressure Wave Form Through the Proxima Device

NCT01672073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2013-08-12

No results posted yet for this study

Summary

The purpose of the trial is to confirm that the presence of the Proxima 3 disposable in the arterial line doesn't significantly attenuate the arterial pressure wave form. The principal aim of the trial will be:

• To obtain quantitative data allowing investigation of the pressure wave form obtained in a standard arterial line compared to various arterial lines fitted with the Proxima 3.

Conditions

  • Local Pressure Effects

Sponsors & Collaborators

  • Sphere Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Thomas Clutton-Brock, MB ChB FRCP · Queen Elizabeth Hopsital, Birmingham, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United Kingdom

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01672073 on ClinicalTrials.gov